About M42
M42 is an Abu Dhabi-based health technology and services group formed through a partnership between G42 and Mubadala. It brings together healthcare providers, genomics and diagnostics businesses and health technology capabilities, with the aim of using data and AI to make healthcare more precise and preventive.
The group combines the health businesses of G42, which include genomics and diagnostics, with healthcare assets from Mubadala Health, which include hospitals and clinics such as Cleveland Clinic Abu Dhabi, Healthpoint and other facilities. This gives M42 both a large clinical network and advanced data and technology capabilities.
Genomics is one of its most prominent areas. M42 has been involved in the Emirati Genome Programme, a national initiative to sequence the genomes of UAE citizens, which is one of the largest population genomics programmes in the world. Genomic data can help identify genetic risks, improve diagnosis and guide personalised treatment.
AI and data analytics support its approach to precision medicine, combining genomic information with clinical data to help doctors make better decisions. Large, well-organised health datasets can also support research into diseases common in the region.
M42's clinical network includes specialised centres in areas such as cancer care, diabetes, eye care, dialysis and fertility, as well as hospitals offering advanced tertiary care. Its providers serve patients in the UAE and, through some businesses, in other countries.
The group has expanded internationally through its businesses and partnerships, taking parts of its model to other markets.
Abu Dhabi has invested heavily in life sciences and health technology, positioning itself as a hub for genomics, biotechnology and healthcare innovation. Government support for data-driven healthcare has enabled large-scale initiatives like the national genome programme.
Precision medicine and preventive care are major trends globally, and M42 aims to be at the forefront in the region.
By combining clinical care with genomics and AI at national scale, M42 is one of the most significant healthtech groups in the UAE, and Startups UAE profiles it among Abu Dhabi's health technology companies.
The group combines the health businesses of G42, which include genomics and diagnostics, with healthcare assets from Mubadala Health, which include hospitals and clinics such as Cleveland Clinic Abu Dhabi, Healthpoint and other facilities. This gives M42 both a large clinical network and advanced data and technology capabilities.
Genomics is one of its most prominent areas. M42 has been involved in the Emirati Genome Programme, a national initiative to sequence the genomes of UAE citizens, which is one of the largest population genomics programmes in the world. Genomic data can help identify genetic risks, improve diagnosis and guide personalised treatment.
AI and data analytics support its approach to precision medicine, combining genomic information with clinical data to help doctors make better decisions. Large, well-organised health datasets can also support research into diseases common in the region.
M42's clinical network includes specialised centres in areas such as cancer care, diabetes, eye care, dialysis and fertility, as well as hospitals offering advanced tertiary care. Its providers serve patients in the UAE and, through some businesses, in other countries.
The group has expanded internationally through its businesses and partnerships, taking parts of its model to other markets.
Abu Dhabi has invested heavily in life sciences and health technology, positioning itself as a hub for genomics, biotechnology and healthcare innovation. Government support for data-driven healthcare has enabled large-scale initiatives like the national genome programme.
Precision medicine and preventive care are major trends globally, and M42 aims to be at the forefront in the region.
By combining clinical care with genomics and AI at national scale, M42 is one of the most significant healthtech groups in the UAE, and Startups UAE profiles it among Abu Dhabi's health technology companies.